Due to CKD, which contraindicates several antidiabetic agents, and also due to the advanced stage of diabetes of most patients, a low number of diabetic patients were only treated with oral antidiabetic agents, not enabling proper statistical comparison of sTfR levels between these patients and those under insulin therapy. The gene discussed is TFRC; the disease is diabetes mellitus.